← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2014-06-18

Drug application

FDA Application #

ANDA203869

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

OXALIPLATIN

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HENGRUI PHARMA

Manufacturer

Sagent Pharmaceuticals

First approval

2014-06-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown